Completed
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
NCT05371054
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States